-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e997bd08-8349-4c9d-8b9e-be21e817a004&Preview=1 -
Date
5/17/2012 -
Company Name
Nurix -
Mailing Address
1700 Owens Street San Francisco, CA 94158 -
Company Description
The company is focused on the discovery and development of small molecule inhibitors of ubiquitin ligases to treat a broad range of proliferative and degenerative diseases. -
Website
http://www.nurix.com -
Transaction Type
Venture Equity -
Transaction Amount
$3,100,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The company will use the proceeds for general working capital purposes. -
M&A Terms
-
Venture Investor
The Column Group -
Venture Investor
Third Rock Ventures













